Abstract
Background
In a low-income country, a child with cancer has severe financial implications for the family. Invariably, patients have to self-finance their therapy. “Out-of-pocket” expenses tend to be high. Also, parents may face loss of job or business resulting in loss of income. Our objective was to assess the financial burden in families with a child with cancer.
Procedure
The cost to a family with a child with acute lymphoblastic leukemia (ALL) during the first month of therapy was analyzed. Fifty families were given a cost diary in which details of expenditure (direct medical costs, living costs, transport cost) and lost income/employment were recorded.
Results
The families evaluated came from a distance of 260 ± 218 km from hospital. Most families belonged to upper lower category (62 %). The medical expenditure amounted to US dollar (USD) 524 (interquartile range (IQR) 395–777). Nonmedical expenditure was USD 207 (IQR 142–293), the maximum expenditure being on food. The monthly expenses were 7.2 times the monthly per capita income of India which was Indian rupee (INR) 5729 (USD 97) in 2012–2013. Thirty-nine families got financial help (USD 800–3225) from various sources, within 6 months of application. Of the families, 72 % families suffered loss of income, 34 % fathers lost their jobs.
Conclusions
Families spend up to seven times their monthly income over a period of 1 month on an unforeseen illness. Despite financial aid from various sources, nonmedical costs amount to nearly 2.5 times the average per capita income. Universal health insurance is the need of the hour.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Parsons SK, Cohen JT, Lichte ML (2011) Economic issues in pediatric cancer. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 6th edn. Wolters Klower Lippincott Williams and Wilkins, Philadelphia, pp 1428–1440
Kim P (2007) Cost of cancer care: the patient perspective. J Clin Oncol 25(2):228–232
Casillas J, Castellino SM, Hudson MM, Mertens AC, Lima IS, Liu Q, Zeltzer LK, Yasuri Y, Robinson LL, Oeffinger KC (2011) Impact of insurance type on survivor focused and general preventive healthcare utilization in adult survivors of childhood cancer. The childhood cancer survivor study (CCSS). Cancer 117(9):1966–1975
Griebsch I, Coast J (2005) Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost utility studies in child health. Pediatrics 115(5):e600–614
Magrath I, Steliarova-Foucher E, Epelmen S, Riberio RC, Harf M, Chi-Kong L, Kebrdi R, Mcfarlane S, Howard SC (2013) Pediatric cancer in low income and middle income countries. Lancet Oncol 14:e104–116
Kumar N, Shekhar C, Kumar P, Kundu AS (2007) Kuppuswamy’s socioeconomic status scale updating for 2007. Ind J Pediatr 74(12):1131–1133
www.who.int/gho/publications/world_health_statistics/2013/en/
Bodkin CN, Piggott TJ, Mann JR (1982) Financial burden of childhood cancer. Br Med J 284:1543–1544
Lansky SB, Black L, Cairns NU (1983) Childhood cancer: medical costs. Cancer 52(4):762–766
Dockerty JD, Skegg DCG, William SM (2003) Economic effects of childhood cancer on families. J Paediatr Child Health 39(4):254–258
Barr R, Furlong W, Henwood T, Feeny D, Wegener J, Walker I, Ml B (1996) Economic evaluation of allogenic bone marrow transplantation: a rudimentary model to generate estimates for the timely formulation of clinical policy. J Clin Oncol 4(5):1413–1420
Newachek PW, Inkelas M, Kim SE (2004) Health services use and health care expenditures in children with disabilities. Pediatrics 114(1):79–85
Limburg H, Shaw AK, McBridge ML (2008) Impact of childhood cancer on parental employment and sources of income: a Canadian pilot study. Pediatr Blood Cancer 51(1):93–98
Miedema B, Easley J, Fortin P, Hamilton R, Mathews M (2008) The economic impact on families when a child is diagnosed with cancer. Curr Oncol 15(4):173–178
Tong WH, van der Sluis IM, Alleman CJM, Litsenburg RR, Kaspers GJL, Pieters R, Uyl-de-Groot CA (2013) Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations; the impact of expensive chemotherapy. Hematologica 98(5):753–759
Houts PS, Lipton A, Harvey HA, Martin B, Simmonds MA, Dixon RH, Longo S, Andrews T, Gordon RA, Meloy J, Hoffman SL (1984) Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer 53(11):2388–2392
Tsimicalis A, Stevens B, Ungan WJ, McKeever P, Greenberg M, Agha M, Guerriere D, Naqvi A, Barr R (2013) A mixed approach to describe the out of pocket expenses incurred by families of children with cancer. Ped Blood Cancer 60:438–445
Bloom BS, Knorr RS, Evans AE (1985) The epidemiology of disease expenses. JAMA 253:2393–2397
De Navas-Walt C, Proctor BD, Lee CH (2005) Income, poverty, and coverage in the United States 2004—current population reports: P60-229.Washington DC, US Census Bureau, pg 16
Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J et al (2013) Planning cancer control in the Latin America and the Caribbean. Lancet Oncol 14:391–436
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghatak, N., Trehan, A. & Bansal, D. Financial burden of therapy in families with a child with acute lymphoblastic leukemia: report from north India. Support Care Cancer 24, 103–108 (2016). https://doi.org/10.1007/s00520-015-2757-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-015-2757-y